google-site-verification: googlec7193c3de77668c9.html

FDA approves Welireg with pembrolizumab for renal cell carcinoma

[
The U.S. Food and Drug Administration has approved Merck’s Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma in adults with a clear cell component at intermediate-high or high risk for recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.


Source link

Advertisements
Views: 1

See also  Cancer survivors from Margate urge others to recognise symptoms

Check Also

For babies hospitalized with bronchiolitis, lying on stomach shows no clear benefit over lying on back

[ Placing a baby on their stomach in the prone position can help them breathe …

Can sunlight make you sneeze?

Do you suffer from Achoo syndrome? Sarah Keith-Lucas explains this unusual condition. BBC News Views: …

Why don’t some people get vaccinated? It’s more complicated than you think

[ If vaccine access is shaped by structural factors, then solutions must go beyond changing …

Leave a Reply

Available for Amazon Prime
cassinox mobil uygulama.